PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20736346-4	2010	The goal of this study was to determine whether the natural compound psoralidin alters EGFR-mediated signaling resulting in the inhibition of prostate cancer growth.	psoralidin	69-79	epidermal growth factor receptor	Mus musculus	87-91	
20736346-6	2010	Treatment with psoralidin, however, inhibited both constitutive and EGF-induced EGFR activation and simultaneously triggered SAPK signaling, resulting in the induction of apoptosis in AIPC cells.	psoralidin	15-25	epidermal growth factor receptor	Mus musculus	80-84	
20736346-7	2010	In addition, psoralidin downregulated EGFR-regulated MAPK signaling and inhibited cell proliferation in AIPC cells.	psoralidin	13-23	epidermal growth factor receptor	Mus musculus	38-42	
20736346-10	2010	Our studies suggest that psoralidin may be a potent therapeutic agent that modulates EGFR-mediated key epigenetic events in AIPC.	psoralidin	25-35	epidermal growth factor receptor	Mus musculus	85-89